Clinical Trials Directory

Trials / Completed

CompletedNCT05266170

The Effect of EX1 Training in Normal Adults

The Effect of EX1 Training on Muscle Activity, Heart Rate, and Respiratory Metabolic Energy Consumption Rate in Normal Adults

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
19 Years – 65 Years
Healthy volunteers
Accepted

Summary

In this study, when performing aerobic and anaerobic exercise with EX1 applied to normal adults between the ages of 19 and 65. The purpose of this study was to determine the effect on the muscle activity of the trunk and lower extremities compared with and without EX1.

Detailed description

In this study, aerobic exercise and anaerobic exercise for normal adults were divided into two visits for a total. For aerobic exercise, the investigators compared the aerobic treadmill walking program without EX1 \[30 minutes of moderate (64-76% HRmax, 12-14 of RPE) aerobic treadmill walking, 40 minutes including warm-up and cool-down times\], the aerobic treadmill walking program with EX1 \[30 minutes of moderate (64-76% HRmax, 12-14 of RPE) aerobic treadmill walking, 40 minutes including warm-up and cool-down times\] , and the high-intensity interval exercise (HIIT) program with EX1 \[High-intensity-low-intensity interval walking exercise was performed at treadmill speed (High: 90-95% HRmax, 15-17 of RPE/Low: 60-70% HRmax, 9-11 of RPE) and EX1 resistance strength (High: resistance intensity 7- 9/Low: Resistance strength 0-2)\] to check the effect on muscle activity, heart rate, and respiratory metabolic energy consumption rate.

Conditions

Interventions

TypeNameDescription
DEVICEaerobic and anaerobic exercises\[aerobic\] 1. Aerobic treadmill walking program without EX1 2. Aerobic treadmill walking program with EX1 3. High-intensity interval exercise (HIIT) program with EX1 \[anaerobic\] 1\. Fitness exercise program with EX1

Timeline

Start date
2022-03-23
Primary completion
2022-12-28
Completion
2022-12-28
First posted
2022-03-04
Last updated
2023-03-01

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05266170. Inclusion in this directory is not an endorsement.